1Kawasaki T.Pediatric Acute Febrile Mucocutaneous Lymph Node Syndrome with Characteristic Desquamation of Fingers and Toes:My Clinical Observation of Fifty Cases[J].the Japanese Journal of Allergy,1967,16(3):178-222.
2Imbach P,Barandun S d'Apuzzo V,et al.High-dose Intravenous Gamma Globulin for Idiopathic Thrombocytopenic Purpura in Childhood[J].Lancet,1981,1:1 228-1 230.
4Morikawa Y,Ohashi Y,Harada K,et al.A Multicenter,Randomized Controlled Trial of Intravenous Gamma Globulin Therapy in Children with Acute Kawasaki Disease[J].Acta Pediatr Jpn,1994,36:347-354.
5Newburger J W,Takahashi M,Beiser A S,et al.Single Infusion of Intravenous Gamma Globulin Compared to Four Daily Doses in the Treatment of Acute Kawasaki Syndrome[J].N Engl J Med,1991,324:1 633-1 639.
6Durongpisitkul K,Gururaj V J,Park J M,et al.The Prevention of Coronary Artery Aneurysm in Kawasaki Disease:a Meta-analysis on the Efficacy of Aspirin and Immunoglobulin Treatment[J].Pediatrics,1995,96:1 057-1 061.
7Terai M,Shulman S T.Prevalence of Coronary Artery Abnormalities in Kawasaki Disease is Highly Dependent on Gamma Globulin Dose but Independent of Salicylate Dose[J].J Pediatr,1997,131:888-893.
8Sawaji Y,Haneda N,Yamaguchi S,et al.Coronary Risk Factors in Acute Kawasaki Disease:Correlation of Serum Immunoglobulin Levels with Coronary Complications[J].Acta Paediatr Jpn,1998,40:218-225.
10Khowsathit P,Hong-HgamC,Khositseth A,et al.Treatment of Kawasaki Disease with a Moderate Dose (1 g/kg) of Intravenous Immunoglobulin[J].J Med Assoc Thai,2002,85(S0):1 121-1 126.
10Hayasaka S,Nakamura Y, Yashiro M. et al. Analyses of fatal cases of Kawasaki disease in Japan using vital statistical data over27years [J ]. JEpidemiol, 2003, 13 ( 5 ) : 246-250.
